MML Investors Services
JAZZ icon

MML Investors Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

MML Investors Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.82M Buy
11,712
+9,231
+372% +$2.02M 0.01% 1329
2026
Q1 		$469K Sell
2,481
-167
-6% -$29.2K ﹤0.01% 2266
2025
Q4 		$450K Sell
2,648
-3,030
-53% -$465K ﹤0.01% 2336
2025
Q3 		$748K Sell
5,678
-7,582
-57% -$909K ﹤0.01% 1916
2025
Q2 		$1.41M Sell
13,260
-3,079
-19% -$334K ﹤0.01% 1464
2025
Q1 		$2.03M Buy
16,339
+1,842
+13% +$240K 0.01% 1175
2024
Q4 		$1.78M Buy
+14,497
New +$1.71M 0.01% 1183
2023
Q1 		– Sell
-4,019
Closed -$640K – 2180
2022
Q4 		$640K Buy
4,019
+1,845
+85% +$270K ﹤0.01% 1374
2022
Q3 		$290K Sell
2,174
-35
-2% -$5.32K ﹤0.01% 1699
2022
Q2 		$345K Buy
2,209
+793
+56% +$122K ﹤0.01% 1599
2022
Q1 		$221K Buy
+1,416
New +$205K ﹤0.01% 1901
2021
Q3 		– Sell
-1,126
Closed -$200K – 1976
2021
Q2 		$200K Buy
+1,126
New +$195K ﹤0.01% 1824
2020
Q3 		– Sell
-2,914
Closed -$322K – 1597
2020
Q2 		$322K Buy
2,914
+59
+2% +$6.52K ﹤0.01% 1197
2020
Q1 		$285K Buy
2,855
+56
+2% +$7.24K ﹤0.01% 1116
2019
Q4 		$418K Buy
2,799
+92
+3% +$12.5K 0.01% 1080
2019
Q3 		$347K Buy
2,707
+114
+4% +$15.3K 0.01% 1108
2019
Q2 		$370K Buy
2,593
+109
+4% +$14.6K 0.01% 1178
2019
Q1 		$355K Sell
2,484
-114
-4% -$14.9K 0.01% 1177
2018
Q4 		$322K Sell
2,598
-161
-6% -$23.9K 0.01% 1136
2018
Q3 		$464K Buy
2,759
+958
+53% +$165K 0.01% 1041
2018
Q2 		$310K Buy
+1,801
New +$294K 0.01% 1067

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

MML Investors Services's JAZZ Position: Q2 2026 in Review

MML Investors Services increased its Jazz Pharmaceuticals (JAZZ) stake by 372% in Q2 2026, buying an estimated $2.02M and bringing the position to 11,712 shares worth $2.82M. The position accounts for 0.01% of the portfolio, ranked #1329.

MML Investors Services first reported a position in JAZZ in Q2 2018 and has held it in 21 quarters since. 303 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • MML Investors Services held 11,712 shares of Jazz Pharmaceuticals worth $2.82M as of Q2 2026.
  • MML Investors Services bought 9,231 Jazz Pharmaceuticals shares in Q2 2026, an estimated $2.02M.
  • Jazz Pharmaceuticals made up 0.01% of MML Investors Services's portfolio in Q2 2026, its #1329 holding.
  • MML Investors Services first reported a position in Jazz Pharmaceuticals in Q2 2018 and has held it in 21 quarters since.
  • 303 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.